img

Global and India THR- β Agonists Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and India THR- β Agonists Market Report & Forecast 2024-2034

THR-β (thyroid hormone receptor-beta) agonists are a class of compounds that activate the thyroid hormone receptor-beta, a nuclear receptor involved in regulating gene expression. These agonists bind to the THR-β receptor and stimulate its activity, leading to various physiological effects.
The global THR- β Agonists revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India, the THR- β Agonists revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of THR- β Agonists include Madrigal Pharmaceuticals, Terns Pharmaceuticals, Ascletis and Haisco Pharmaceutical Group, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India THR- β Agonists market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for THR- β Agonists will continue to grow rapidly in the future.
Global THR- β Agonists Scope and Market Size
THR- β Agonists market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global THR- β Agonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the THR- β Agonists market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.



By Company


Madrigal Pharmaceuticals
Terns Pharmaceuticals
Ascletis
Haisco Pharmaceutical Group
Segment by Type
Specification Below 10mg
Specification 10-50mg
Specification Above 50mg

Segment by Application


Metabolic Diseases
Cardiovascular Disease
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces THR- β Agonists definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of THR- β Agonists companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of THR- β Agonists in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, THR- β Agonists revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 THR- β Agonists Product Introduction
1.2 Global THR- β Agonists Outlook 2018 VS 2022 VS 2033
1.2.1 Global THR- β Agonists Market Size for the Year 2018-2033
1.2.2 India THR- β Agonists Market Size for the Year 2018-2033
1.3 THR- β Agonists Market Size, India VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of India THR- β Agonists in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of THR- β Agonists Market Size, India VS Global, 2018 VS 2022 VS 2033
1.4 THR- β Agonists Market Dynamics
1.4.1 THR- β Agonists Industry Trends
1.4.2 THR- β Agonists Market Drivers
1.4.3 THR- β Agonists Market Challenges
1.4.4 THR- β Agonists Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 THR- β Agonists by Type
2.1 THR- β Agonists Market Segment by Type
2.1.1 Specification Below 10mg
2.1.2 Specification 10-50mg
2.1.3 Specification Above 50mg
2.2 Global THR- β Agonists Market Size by Type (2018, 2022 & 2033)
2.3 Global THR- β Agonists Market Size by Type (2018-2033)
2.4 India THR- β Agonists Market Size by Type (2018, 2022 & 2033)
2.5 India THR- β Agonists Market Size by Type (2018-2033)
3 THR- β Agonists by Application
3.1 THR- β Agonists Market Segment by Application
3.1.1 Metabolic Diseases
3.1.2 Cardiovascular Disease
3.1.3 Others
3.2 Global THR- β Agonists Market Size by Application (2018, 2022 & 2033)
3.3 Global THR- β Agonists Market Size by Application (2018-2033)
3.4 India THR- β Agonists Market Size by Application (2018, 2022 & 2033)
3.5 India THR- β Agonists Market Size by Application (2018-2033)
4 Global THR- β Agonists Competitor Landscape by Company
4.1 Global THR- β Agonists Market Size by Company
4.1.1 Global Key Companies of THR- β Agonists, Ranked by Revenue (2022)
4.1.2 Global THR- β Agonists Revenue by Player (2018-2023)
4.2 Global THR- β Agonists Concentration Ratio (CR)
4.2.1 THR- β Agonists Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of THR- β Agonists in 2022
4.2.3 Global THR- β Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of THR- β Agonists Head office and Area Served
4.4 Global Key Players of THR- β Agonists, Product and Application
4.5 Global Key Players of THR- β Agonists, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India THR- β Agonists Market Size by Company
4.7.1 Key Players of THR- β Agonists in India, Ranked by Revenue (2022)
4.7.2 India THR- β Agonists Revenue by Players (2021, 2022 & 2023)
5 Global THR- β Agonists Market Size by Region
5.1 Global THR- β Agonists Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global THR- β Agonists Market Size by Region (2018-2033)
5.2.1 Global THR- β Agonists Market Size by Region: 2018-2023
5.2.2 Global THR- β Agonists Market Size by Region (2024-2033)
6 Americas
6.1 Americas THR- β Agonists Market Size YoY Growth 2018-2033
6.2 Americas THR- β Agonists Market Size by Type
6.2.1 Americas THR- β Agonists Market Size by Type (2018-2023)
6.2.2 Americas THR- β Agonists Market Size by Type (2024-2033)
6.2.3 Americas THR- β Agonists Market Share by Type (2018-2033)
6.3 Americas THR- β Agonists Market Size by Application
6.3.1 Americas THR- β Agonists Market Size by Application (2018-2023)
6.3.2 Americas THR- β Agonists Market Size by Application (2024-2033)
6.3.3 Americas THR- β Agonists Market Share by Application (2018-2033)
6.4 Americas THR- β Agonists Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA THR- β Agonists Market Size YoY Growth 2018-2033
7.2 EMEA THR- β Agonists Market Size by Type
7.2.1 EMEA THR- β Agonists Market Size by Type (2018-2023)
7.2.2 EMEA THR- β Agonists Market Size by Type (2024-2033)
7.2.3 EMEA THR- β Agonists Market Share by Type (2018-2033)
7.3 EMEA THR- β Agonists Market Size by Application
7.3.1 EMEA THR- β Agonists Market Size by Application (2018-2023)
7.3.2 EMEA THR- β Agonists Market Size by Application (2024-2033)
7.3.3 EMEA THR- β Agonists Market Share by Application (2018-2033)
7.4 EMEA THR- β Agonists Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China THR- β Agonists Market Size YoY Growth 2018-2033
8.2 China THR- β Agonists Market Size by Type
8.2.1 China THR- β Agonists Market Size by Type (2018-2023)
8.2.2 China THR- β Agonists Market Size by Type (2024-2033)
8.2.3 China THR- β Agonists Market Share by Type (2018-2033)
8.3 China THR- β Agonists Market Size by Application
8.3.1 China THR- β Agonists Market Size by Application (2018-2023)
8.3.2 China THR- β Agonists Market Size by Application (2024-2033)
8.3.3 China THR- β Agonists Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC THR- β Agonists Market Size YoY Growth 2018-2033
9.2 APAC THR- β Agonists Market Size by Type
9.2.1 APAC THR- β Agonists Market Size by Type (2018-2023)
9.2.2 APAC THR- β Agonists Market Size by Type (2024-2033)
9.2.3 APAC THR- β Agonists Market Share by Type (2018-2033)
9.3 APAC THR- β Agonists Market Size by Application
9.3.1 APAC THR- β Agonists Market Size by Application (2018-2023)
9.3.2 APAC THR- β Agonists Market Size by Application (2024-2033)
9.3.3 APAC THR- β Agonists Market Share by Application (2018-2033)
9.4 APAC THR- β Agonists Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Madrigal Pharmaceuticals
10.1.1 Madrigal Pharmaceuticals Company Details
10.1.2 Madrigal Pharmaceuticals Business Overview
10.1.3 Madrigal Pharmaceuticals THR- β Agonists Introduction
10.1.4 Madrigal Pharmaceuticals Revenue in THR- β Agonists Business (2018-2023)
10.1.5 Madrigal Pharmaceuticals Recent Development
10.2 Terns Pharmaceuticals
10.2.1 Terns Pharmaceuticals Company Details
10.2.2 Terns Pharmaceuticals Business Overview
10.2.3 Terns Pharmaceuticals THR- β Agonists Introduction
10.2.4 Terns Pharmaceuticals Revenue in THR- β Agonists Business (2018-2023)
10.2.5 Terns Pharmaceuticals Recent Development
10.3 Ascletis
10.3.1 Ascletis Company Details
10.3.2 Ascletis Business Overview
10.3.3 Ascletis THR- β Agonists Introduction
10.3.4 Ascletis Revenue in THR- β Agonists Business (2018-2023)
10.3.5 Ascletis Recent Development
10.4 Haisco Pharmaceutical Group
10.4.1 Haisco Pharmaceutical Group Company Details
10.4.2 Haisco Pharmaceutical Group Business Overview
10.4.3 Haisco Pharmaceutical Group THR- β Agonists Introduction
10.4.4 Haisco Pharmaceutical Group Revenue in THR- β Agonists Business (2018-2023)
10.4.5 Haisco Pharmaceutical Group Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. THR- β Agonists Market Size India VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. THR- β Agonists Market Trends
Table 3. THR- β Agonists Market Drivers
Table 4. THR- β Agonists Market Challenges
Table 5. THR- β Agonists Market Restraints
Table 6. Global THR- β Agonists Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. India THR- β Agonists Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global THR- β Agonists Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. India THR- β Agonists Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of THR- β Agonists, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global THR- β Agonists Revenue by Player, (US$ Million), 2018-2023
Table 12. Global THR- β Agonists Revenue Share by Player, 2018-2023
Table 13. Global THR- β Agonists Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global THR- β Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in THR- β Agonists as of 2022)
Table 15. Global Key Players of THR- β Agonists, Headquarters and Area Served
Table 16. Global Key Players of THR- β Agonists, Product and Application
Table 17. Global Key Players of THR- β Agonists, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of THR- β Agonists in India, Ranked by Revenue (2022) & (US$ Million)
Table 20. India THR- β Agonists Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. India THR- β Agonists Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global THR- β Agonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global THR- β Agonists Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global THR- β Agonists Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas THR- β Agonists Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas THR- β Agonists Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas THR- β Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas THR- β Agonists Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA THR- β Agonists Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA THR- β Agonists Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA THR- β Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA THR- β Agonists Market Size by Country (2024-2033) & (US$ Million)
Table 39. China THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
Table 40. China THR- β Agonists Market Size by Type (2024-2033) & (US$ Million)
Table 41. China THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
Table 42. China THR- β Agonists Market Size by Application (2024-2033) & (US$ Million)
Table 43. China THR- β Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC THR- β Agonists Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC THR- β Agonists Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC THR- β Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC THR- β Agonists Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC THR- β Agonists Market Size by Region (2024-2033) & (US$ Million)
Table 51. Madrigal Pharmaceuticals Company Details
Table 52. Madrigal Pharmaceuticals Business Overview
Table 53. Madrigal Pharmaceuticals THR- β Agonists Product
Table 54. Madrigal Pharmaceuticals Revenue in THR- β Agonists Business (2018-2023) & (US$ Million)
Table 55. Madrigal Pharmaceuticals Recent Development
Table 56. Terns Pharmaceuticals Company Details
Table 57. Terns Pharmaceuticals Business Overview
Table 58. Terns Pharmaceuticals THR- β Agonists Product
Table 59. Terns Pharmaceuticals Revenue in THR- β Agonists Business (2018-2023) & (US$ Million)
Table 60. Terns Pharmaceuticals Recent Development
Table 61. Ascletis Company Details
Table 62. Ascletis Business Overview
Table 63. Ascletis THR- β Agonists Product
Table 64. Ascletis Revenue in THR- β Agonists Business (2018-2023) & (US$ Million)
Table 65. Ascletis Recent Development
Table 66. Haisco Pharmaceutical Group Company Details
Table 67. Haisco Pharmaceutical Group Business Overview
Table 68. Haisco Pharmaceutical Group THR- β Agonists Product
Table 69. Haisco Pharmaceutical Group Revenue in THR- β Agonists Business (2018-2023) & (US$ Million)
Table 70. Haisco Pharmaceutical Group Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. THR- β Agonists Product Picture
Figure 2. Global THR- β Agonists Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global THR- β Agonists Market Size 2018-2033 (US$ Million)
Figure 4. India THR- β Agonists Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. India THR- β Agonists Market Size 2018-2033 (US$ Million)
Figure 6. India THR- β Agonists Market Share in Global 2018-2033
Figure 7. THR- β Agonists Report Years Considered
Figure 8. Product Picture of Specification Below 10mg
Figure 9. Product Picture of Specification 10-50mg
Figure 10. Product Picture of Specification Above 50mg
Figure 11. Global THR- β Agonists Market Share by Type in 2022 & 2033
Figure 12. Global THR- β Agonists Market Size by Type (2018-2033) & (US$ Million)
Figure 13. Global THR- β Agonists Market Share by Type (2018-2033)
Figure 14. India THR- β Agonists Market Share by Type in 2022 & 2033
Figure 15. India THR- β Agonists Market Size by Type (2018-2033) & (US$ Million)
Figure 16. India THR- β Agonists Market Share by Type (2018-2033)
Figure 17. Product Picture of Metabolic Diseases
Figure 18. Product Picture of Cardiovascular Disease
Figure 19. Product Picture of Others
Figure 20. Global THR- β Agonists Market Share by Application in 2022 & 2033
Figure 21. Global THR- β Agonists Market Size by Application (2018-2033) & (US$ Million)
Figure 22. Global THR- β Agonists Market Share by Application (2018-2033)
Figure 23. India THR- β Agonists Market Share by Application in 2022 & 2033
Figure 24. India THR- β Agonists Market Size by Application (2018-2033) & (US$ Million)
Figure 25. India THR- β Agonists Market Share by Application (2018-2033)
Figure 26. The Top 5 and 10 Largest Companies of THR- β Agonists in the World: Market Share by THR- β Agonists Revenue in 2022
Figure 27. Global THR- β Agonists Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 28. Global THR- β Agonists Market Share by Region (2018-2033)
Figure 29. Americas THR- β Agonists Market Size Growth Rate 2018-2033 (US$ Million)
Figure 30. Americas THR- β Agonists Market Share by Type (2018-2033)
Figure 31. Americas THR- β Agonists Market Share by Application (2018-2033)
Figure 32. United States THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Canada THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Mexico THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Brazil THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. EMEA THR- β Agonists Market Size Growth Rate 2018-2033 (US$ Million)
Figure 37. EMEA THR- β Agonists Market Share by Type (2018-2033)
Figure 38. EMEA THR- β Agonists Market Share by Application (2018-2033)
Figure 39. Europe THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Middle East THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Africa THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. China THR- β Agonists Market Size Growth Rate 2018-2033 (US$ Million)
Figure 43. China THR- β Agonists Market Share by Type (2018-2033)
Figure 44. China THR- β Agonists Market Share by Application (2018-2033)
Figure 45. APAC THR- β Agonists Market Size Growth Rate 2018-2033 (US$ Million)
Figure 46. APAC THR- β Agonists Market Share by Type (2018-2033)
Figure 47. APAC THR- β Agonists Market Share by Application (2018-2033)
Figure 48. Japan THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. South Korea THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. China Taiwan THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. Southeast Asia THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. India THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. Madrigal Pharmaceuticals Revenue Growth Rate in THR- β Agonists Business (2018-2023)
Figure 54. Terns Pharmaceuticals Revenue Growth Rate in THR- β Agonists Business (2018-2023)
Figure 55. Ascletis Revenue Growth Rate in THR- β Agonists Business (2018-2023)
Figure 56. Haisco Pharmaceutical Group Revenue Growth Rate in THR- β Agonists Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed